Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial-Reference-Cited by-同舟云学术

Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial

Published:2018-06 Issue:6 Volume:73 Page:968-976
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Kass-Iliyya Antoine,Jovic Gordana,Murphy Claire,Fisher Cyril,Syndikus Isabel,Jose Chakiath,Scrase Christopher D.,Graham John D.,Nicol David,Sydes Matthew R.,Dearnaley David^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma;Crook;Cancer,1997

2. Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer;Cohen;Int Braz J Urol,2010

3. Diagnosis of prostate cancer in needle biopsies after radiation therapy;Cheng;Am J Surg Pathol,1999

4. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients;Crook;Int J Radiat Oncol Biol Phys,2000

5. Radical prostatectomy and radical radiation therapy for clinical stages T1 to 2 adenocarcinoma of the prostate: new insights into outcome from repeat biopsy and prostate specific antigen followup;Zietman;J Urol,1994

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up;Journal of Clinical Oncology;2024-06-01

2. Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis;Radiotherapy and Oncology;2024-05

3. Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN);European Urology;2022-11

5. Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy;Cancers;2022-09-15